4
MARKET OVERVIEW
Digital health transformation accelerates with AI, telehealth, and personalized care, despite integration challenges.
45
4.2.1.1
RISING DEMAND FOR DIGITAL ENGAGEMENT PLATFORMS AND PERSONALIZED PATIENT CARE
4.2.1.2
INCREASING ADOPTION OF TELEHEALTH, MOBILE HEALTH APPS, AND AI-POWERED ANALYTICS
4.2.1.3
GOVERNMENT INITIATIVES AND FUNDING FOR HEALTHCARE DIGITAL TRANSFORMATION
4.2.1.4
GROWING FOCUS ON IMPROVING PATIENT SATISFACTION AND LONG-TERM ENGAGEMENT
4.2.1.5
EXPANSION OF CLOUD-BASED ENGAGEMENT PLATFORMS
4.2.2.1
DATA PRIVACY AND CYBERSECURITY CONCERNS
4.2.2.2
HIGH IMPLEMENTATION AND INTEGRATION COSTS FOR HEALTHCARE PROVIDERS
4.2.2.3
LIMITED INTEROPERABILITY BETWEEN PATIENT ENGAGEMENT SYSTEMS AND EXISTING ELECTRONIC HEALTH RECORD SYSTEMS
4.2.3.1
GROWTH OPPORTUNITIES IN EMERGING MARKET
4.2.3.2
ADOPTION OF AI-DRIVEN PERSONALIZATION AND PREDICTIVE ANALYTICS FOR PATIENT CARE
4.2.3.3
STRATEGIC PARTNERSHIPS AMONG TECHNOLOGY PROVIDERS, PHARMA COMPANIES, AND PAYERS
4.2.3.4
RISING ADOPTION OF VIRTUAL REALITY AND AUGMENTED REALITY
4.2.4.1
NEED TO ENSURE ACCURACY AND RELIABILITY OF FEEDBACK DATA
4.2.4.2
RAPID TECHNOLOGICAL EVOLUTION
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and digital healthcare trends to leverage market shifts and investment opportunities.
56
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
BARGAINING POWER OF SUPPLIERS
5.3
BARGAINING POWER OF BUYERS
5.4
THREAT OF NEW ENTRANTS
5.5
THREAT OF SUBSTITUTES
5.6
INTENSITY OF COMPETITIVE RIVALRY
5.7
MACROECONOMIC INDICATORS
5.7.2
GDP TRENDS AND FORECAST
5.7.3
HEALTHCARE DIGITALIZATION AND PATIENT ENGAGEMENT ADOPTION TRENDS
5.8.1
PRODUCT DESIGN & DEVELOPMENT
5.8.2
SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION
5.8.3
IMPLEMENTATION & CHANGE MANAGEMENT
5.8.4
EXPERIENCE ANALYTICS & REPORTING INSIGHTS
5.8.5
POST-SALES SUPPORT & CONTINUOUS IMPROVEMENT
5.10.1
AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.10.2
AVERAGE SELLING PRICE TREND, BY REGION
5.11
KEY CONFERENCES AND EVENTS, 2026–2027
5.12
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.13
INVESTMENT AND FUNDING SCENARIO
5.15
IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET
5.15.3
IMPACT ON COUNTRY/REGION
5.15.4
IMPACT ON END USERS
5.15.4.1
HEALTHCARE PROVIDERS
5.15.4.2
HEALTHCARE PAYERS
5.15.4.3
PHARMA & BIOTECH COMPANIES
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
Leverage AI and patents to revolutionize patient engagement and predictive healthcare solutions.
74
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
VOICE-OF-THE-PATIENT (VOP) PLATFORMS
6.1.2
TELEHEALTH AND VIRTUAL CARE PLATFORMS
6.1.3
PATIENT PORTALS AND PERSONAL HEALTH RECORDS
6.1.4
REMOTE PATIENT MONITORING (RPM)
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
INTEROPERABILITY/API AND FHIR INFRASTRUCTURE
6.2.2
PATIENT IDENTITY MANAGEMENT AND AUTHENTICATION SYSTEMS
6.3
ADJACENT TECHNOLOGIES
6.3.1
CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
6.3.2
POPULATION HEALTH MANAGEMENT (PHM) PLATFORMS
6.3.3
PATIENT ENGAGEMENT SOLUTIONS
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
PATENT PUBLICATION TRENDS
6.5.2
JURISDICTION ANALYSIS
6.5.3
MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
6.6.1
AI-POWERED DIGITAL FRONT DOOR AND INTELLIGENT PATIENT NAVIGATION
6.6.2
PREDICTIVE AND PROACTIVE PATIENT EXPERIENCE MANAGEMENT
6.6.3
PERSONALIZED, OMNICHANNEL, AND CONNECTED PATIENT ENGAGEMENT
7
REGULATORY LANDSCAPE
Navigate complex global regulations with region-specific compliance insights and authoritative agency details.
83
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY ANALYSIS
7.1.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Discover unmet needs and key buying criteria shaping end-user expectations in top industries.
94
8.2
DECISION-MAKING PROCESS
8.3
KEY STAKEHOLDERS AND BUYING CRITERIA
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.3.2
KEY BUYING CRITERIA
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.4.2
END-USER EXPECTATIONS
9
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
100
9.2
APPOINTMENT SCHEDULING
9.2.1
ENABLING OPERATIONAL EFFICIENCY AND PATIENT ACCESS
9.3.1
OPTIMIZING FRONT-END WORKFLOWS AND DATA ACCURACY
9.4.1
EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE
9.5
PATIENT COMMUNICATION
9.5.1
DRIVING PATIENT ACTIVATION AND CARE ADHERENCE
9.6.1
PUSH FOR TRANSPARENT & AUTOMATED FINANCIAL WORKFLOWS
9.7.1
FACILITATING CONTINUOUS IMPROVEMENT IN PATIENT EXPERIENCE
9.8.1
GROWING FOCUS ON HOLISTIC, PATIENT-CENTRIC CARE
10
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 10 Data Tables
112
10.2.1
ON-PREMISE SOFTWARE
10.2.1.1
ENSURING DATA CONTROL, COMPLIANCE, AND SYSTEM INTEGRATION
10.2.2.1
LOWER UPFRONT COSTS AND SEAMLESS INTEROPERABILITY TO AID GROWTH
10.2.3.1
ABILITY TO ENSURE MAXIMUM COMPLIANCE AND CONTROL TO BOOST MARKET
10.3.1.1
RISING DEMAND FOR OPERATIONAL EFFICIENCY AND RISK MITIGATION TO ENCOURAGE GROWTH
10.3.2
PROFESSIONAL SERVICES
10.3.2.1
NEED FOR CONTINUOUS PATIENT ENGAGEMENT TO CONTRIBUTE TO GROWTH
11
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 11 Data Tables
123
11.1.1
HEALTHCARE PROVIDERS
11.1.1.1
GROWING PATIENT EXPECTATIONS AND DIGITAL-FIRST STRATEGIES
11.1.2
HOSPITALS & HEALTH SYSTEMS
11.1.2.1
ENTERPRISE-WIDE DIGITAL PLATFORMS TO UNIFY PATIENT JOURNEYS AND OPTIMIZE VALUE-BASED CARE
11.1.3
OUTPATIENT & AMBULATORY CARE CENTERS
11.1.3.1
DIGITAL TRANSFORMATION ELEVATES PATIENT EXPERIENCE IN AMBULATORY SETTINGS
11.1.4
PHYSICIAN & GROUP PRACTICES
11.1.4.1
AI, EHRS, AND MOBILE APPS TRANSFORM CARE DELIVERY IN GROUP PRACTICES
11.1.5
LONG-TERM CARE & POST-ACUTE FACILITIES
11.1.5.1
ENHANCING CARE QUALITY AND PATIENT EXPERIENCE IN LTC AND PAC FACILITIES
11.1.6
OTHER HEALTHCARE PROVIDERS
11.1.6.1
IMPROVING PATIENT ENGAGEMENT AND CARE EFFICIENCY ACROSS SPECIALTY AND AMBULATORY SETTINGS TO DRIVE SEGMENT
11.2.1
ADVANCING MEMBER-CENTRIC CARE TO BOOST GROWTH
11.3
PHARMA & BIOTECH COMPANIES
11.3.1
PHARMA & BIOTECH ADVANCING PATIENT EXPERIENCE THROUGH DIGITAL SOLUTIONS
11.4.1
ENABLERS OF STANDARDS, COMPLIANCE, AND INNOVATION DRIVING PATIENT EXPERIENCE TECHNOLOGY ADOPTION
12
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 174 Data Tables.
139
12.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2.1
US TO DOMINATE GLOBAL MARKET FOR PATIENT EXPERIENCE TECHNOLOGY
12.2.3.1
ADVANCING PATIENT-CENTRIC DIGITAL HEALTH SOLUTIONS
12.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2.1
NHS-DRIVEN PATIENT-CENTRIC INNOVATION
12.3.3.1
DIGITAL HEALTH LEADERSHIP AND PATIENT ENGAGEMENT
12.3.4.1
ADVANCING PATIENT-CENTRIC DIGITAL HEALTH
12.3.5.1
REGIONAL GROWTH AND TELEMEDICINE EXPANSION
12.3.6.1
PATIENT-CENTRIC DIGITAL HEALTH AND REGIONAL INNOVATION
12.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2.1
RAPIDLY GROWING ELDERLY POPULATION TO PROPEL MARKET EXPANSION
12.4.3.1
WIDESPREAD SUPER-APP INTEGRATION TO ACCELERATE ADOPTION
12.4.4.1
NATIONAL DIGITAL HEALTH PROGRAMS ACCELERATING MARKET GROWTH IN INDIA
12.4.5.1
REGULATORY LIBERALIZATION AND ICT INTEGRATION FUELING MARKET GROWTH
12.4.6.1
MATURE HEALTHCARE SYSTEM AND DIGITAL INFRASTRUCTURE DRIVING ADOPTION
12.4.7
REST OF ASIA PACIFIC
12.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2.1
BRAZIL TO DOMINATE PATIENT EXPERIENCE TECHNOLOGY MARKET IN LATIN AMERICA
12.5.3.1
MEXICO EMERGES AS A HUB FOR RETAIL-INTEGRATED AND MULTILINGUAL PATIENT EXPERIENCE PLATFORMS
12.5.4
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2.1
RISING HEALTHCARE INVESTMENTS TO FUEL UPTAKE
12.6.2.2.1
VISION 2030 AND MOH DIGITAL-FIRST STRATEGY
12.6.2.3.1
GOVERNMENT-LED DIGITAL TRANSFORMATION AND PRIVATE-SECTOR INNOVATION
12.6.2.4.1
RISING DEMAND FOR TELEHEALTH & VIRTUAL CARE
12.6.4
REST OF MIDDLE EAST & AFRICA
13
COMPETITIVE LANDSCAPE
Discover top strategies and market dynamics shaping patient experience technology leaders by 2025.
232
13.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
13.3
REVENUE ANALYSIS, 2021–2025
13.4
MARKET SHARE ANALYSIS, 2025
13.5
COMPANY VALUATION AND FINANCIAL METRICS
13.6
BRAND/SOFTWARE COMPARISON
13.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.7.5.1
COMPANY FOOTPRINT
13.7.5.2
REGION FOOTPRINT
13.7.5.3
OFFERING FOOTPRINT
13.7.5.4
FUNCTION FOOTPRINT
13.7.5.5
END USER FOOTPRINT
13.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.8.1
PROGRESSIVE COMPANIES
13.8.2
RESPONSIVE COMPANIES
13.8.5
COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
13.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.9
COMPETITIVE SCENARIO
13.9.1
SOLUTION/SERVICE LAUNCHES
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
257
14.1.1.1
BUSINESS OVERVIEW
14.1.1.2
SOLUTIONS OFFERED
14.1.1.3
RECENT DEVELOPMENTS
14.1.1.3.1
SOLUTION LAUNCHES AND ENHANCEMENTS
14.1.1.4.2
STRATEGIC CHOICES
14.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
14.1.2
NATIONAL RESEARCH CORPORATION
14.1.7
EPIC SYSTEMS CORPORATION
14.1.11
GETWELLNETWORK, INC.
14.1.12
CIPHERHEALTH INC.
14.2.4
BUSINESS INTEGRITY SERVICES
15
RESEARCH METHODOLOGY
322
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
BREAKDOWN OF PRIMARY SOURCES
15.2
RESEARCH METHODOLOGY DESIGN
15.3
MARKET SIZE ESTIMATION
15.4
MARKET BREAKDOWN & DATA TRIANGULATION
15.5
RESEARCH ASSUMPTIONS
15.5.1
MARKET SIZING ASSUMPTIONS
15.5.2
OVERALL STUDY ASSUMPTIONS
15.7
RESEARCH LIMITATIONS
15.7.1
METHODOLOGY-RELATED LIMITATIONS
15.7.2
SCOPE-RELATED LIMITATIONS
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
TABLE 1
USD EXCHANGE RATES
TABLE 2
PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3
PATIENT EXPERIENCE TECHNOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 4
AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE SOFTWARE, BY KEY PLAYER, 2022–2025 (USD)
TABLE 5
AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY, BY REGION, 2022–2025 (USD)
TABLE 6
PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 7
CASE STUDY 1: IMPROVED PATIENT-CENTERED CARE WITH DIGIVALET PATIENT EXPERIENCE PLATFORM
TABLE 8
CASE STUDY 2: PAPERLESS ADMISSIONS VIA PWC + SALESFORCE DIGITAL PATIENT PORTAL
TABLE 9
CASE STUDY 3: TIMELY PATIENT COMMUNICATIONS WITH TWILIO MESSAGING
TABLE 10
CASE STUDY 4: DIGITAL WAYFINDING & WI-FI ENHANCEMENTS BY WORLDWIDE TECHNOLOGY
TABLE 11
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT EXPERIENCE TECHNOLOGY
TABLE 13
PATIENT EXPERIENCE TECHNOLOGY MARKET: KEY PATENTS/PATENT APPLICATIONS
TABLE 14
REGULATORY SCENARIO IN NORTH AMERICA
TABLE 15
REGULATORY SCENARIO IN EUROPE
TABLE 16
REGULATORY SCENARIO IN ASIA PACIFIC
TABLE 17
REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
TABLE 18
REGULATORY SCENARIO IN LATIN AMERICA
TABLE 19
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 25
KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 26
PATIENT EXPERIENCE TECHNOLOGY MARKET: UNMET NEEDS
TABLE 27
PATIENT EXPERIENCE TECHNOLOGY MARKET: END-USER EXPECTATIONS
TABLE 28
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 29
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR APPOINTMENT SCHEDULING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 30
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT REGISTRATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR VIRTUAL CARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PATIENT COMMUNICATION, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR BILLING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR FEEDBACK MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 37
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY DEPLOYMENT, 2024–2031 (USD MILLION)
TABLE 38
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR ON-PREMISE SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2024–2031 (USD MILLION)
TABLE 41
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HYBRID SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY SERVICE, 2024–2031 (USD MILLION)
TABLE 43
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR MANAGED SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 47
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 48
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HOSPITALS & HEALTH SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OUTPATIENT & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHYSICIAN & GROUP PRACTICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR LONG-TERM CARE & POST-ACUTE FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
PATIENT EXPERIENCE TECHNOLOGY MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
PATIENT EXPERIENCE TECHNOLOGY FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57
PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 58
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 60
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 61
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 63
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 64
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 65
US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 66
US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 67
US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 68
US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 69
US: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 70
US: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 71
CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 72
CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 73
CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 74
CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 75
CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 76
CANADA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 77
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 79
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 80
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 81
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 82
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 83
EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 84
UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 85
UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 86
UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 87
UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 88
UK: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 89
UK: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90
GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 91
GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 92
GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93
GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 94
GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 95
GERMANY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96
FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 97
FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 98
FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 99
FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 100
FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 101
FRANCE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102
ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 103
ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104
ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105
ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 106
ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 107
ITALY: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108
SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 109
SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110
SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111
SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 112
SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113
SPAIN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114
REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 115
REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116
REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117
REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 118
REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 119
REST OF EUROPE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 121
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 122
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 125
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 126
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127
JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 128
JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 129
JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130
JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 131
JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 132
JAPAN: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133
CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 134
CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136
CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 137
CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 138
CHINA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 139
INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 140
INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141
INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 142
INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 143
INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 144
INDIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 146
SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147
SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148
SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 149
SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 150
SOUTH KOREA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151
AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 152
AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153
AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 155
AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 156
AUSTRALIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157
REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 158
REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 159
REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160
REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 161
REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 162
REST OF ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 163
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 164
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 165
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 168
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 169
LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 170
BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 171
BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172
BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 173
BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 174
BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 175
BRAZIL: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176
MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 177
MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178
MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179
MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 180
MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 181
MEXICO: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 182
REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 183
REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184
REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185
REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 186
REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 187
REST OF LATIN AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 189
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 190
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 193
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 194
MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 196
GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197
GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198
GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 199
GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 200
GCC COUNTRIES: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201
SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 202
SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203
SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 204
SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 205
SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206
SAUDI ARABIA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207
UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 208
UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209
UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210
UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 211
UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 212
UAE: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213
REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 214
REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216
REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 217
REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 218
REST OF GCC: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219
SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 220
SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221
SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222
SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 223
SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 224
SOUTH AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225
REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 226
REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SOFTWARE/PLATFORM, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227
REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228
REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 229
REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 230
REST OF MIDDLE EAST & AFRICA: PATIENT EXPERIENCE TECHNOLOGY MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, JANUARY 2023–JULY 2026
TABLE 232
PATIENT EXPERIENCE TECHNOLOGY MARKET: DEGREE OF COMPETITION
TABLE 233
PATIENT EXPERIENCE TECHNOLOGY MARKET: REGION FOOTPRINT
TABLE 234
PATIENT EXPERIENCE TECHNOLOGY MARKET: OFFERING FOOTPRINT
TABLE 235
PATIENT EXPERIENCE TECHNOLOGY MARKET: FUNCTION FOOTPRINT
TABLE 236
PATIENT EXPERIENCE TECHNOLOGY MARKET: END USER FOOTPRINT
TABLE 237
PATIENT EXPERIENCE TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 238
PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 239
PATIENT EXPERIENCE TECHNOLOGY MARKET: SOLUTION/SERVICE LAUNCHES, JANUARY 2023–JULY 2026
TABLE 240
PATIENT EXPERIENCE TECHNOLOGY MARKET: DEALS, JANUARY 2023 - JULY 2026
TABLE 241
PATIENT EXPERIENCE TECHNOLOGY MARKET: EXPANSIONS, JANUARY 2023 - JULY 2026
TABLE 242
PRESS GANEY: COMPANY OVERVIEW
TABLE 243
PRESS GANEY: SOLUTIONS OFFERED
TABLE 244
PRESS GANEY: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 245
PRESS GANEY: DEALS, JANUARY 2023–JULY 2026
TABLE 246
NATIONAL RESEARCH CORPORATION: COMPANY OVERVIEW
TABLE 247
NATIONAL RESEARCH CORPORATION: SOLUTIONS OFFERED
TABLE 248
NATIONAL RESEARCH CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 249
MEDALLIA INC.: COMPANY OVERVIEW
TABLE 250
MEDALLIA INC.: SOLUTIONS OFFERED
TABLE 251
MEDALLIA INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 252
MEDALLIA INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 253
PHREESIA: COMPANY OVERVIEW
TABLE 254
PHREESIA: SOLUTIONS OFFERED
TABLE 255
PHREESIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 256
PHREESIA: DEALS, JANUARY 2023–JULY 2026
TABLE 257
NICE: COMPANY OVERVIEW
TABLE 258
NICE: SOLUTIONS OFFERED
TABLE 259
R1: COMPANY OVERVIEW
TABLE 260
R1: SOLUTIONS OFFERED
TABLE 261
R1 RCM INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 262
R1: DEALS, JANUARY 2023–JULY 2026
TABLE 263
EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 264
EPIC SYSTEMS CORPORATION: SOLUTIONS OFFERED
TABLE 265
EPIC SYSTEMS CORPORATION: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 266
EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023–JULY 2026
TABLE 267
IQVIA: COMPANY OVERVIEW
TABLE 268
IQVIA: SOLUTIONS OFFERED
TABLE 269
IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 270
QUALTRICS: COMPANY OVERVIEW
TABLE 271
QUALTRICS: SOLUTIONS OFFERED
TABLE 272
QUALTRICS: DEALS, JANUARY 2023–JULY 2026
TABLE 273
QUALTRICS: EXPANSIONS, JANUARY 2023–JULY 2026
TABLE 274
QUALTRICS: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 275
RELIAS LLC: COMPANY OVERVIEW
TABLE 276
RELIAS LLC: SOLUTIONS OFFERED
TABLE 277
RELIAS LLC: DEALS, JANUARY 2023–JULY 2026
TABLE 278
GETWELLNETWORK, INC.: COMPANY OVERVIEW
TABLE 279
GETWELLNETWORK, INC.: SOLUTIONS OFFERED
TABLE 280
GETWELLNETWORK, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 281
GETWELLNETWORK, INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 282
CIPHERHEALTH INC.: COMPANY OVERVIEW
TABLE 283
CIPHERHEALTH INC.: SOLUTIONS OFFERED
TABLE 284
CIPHERHEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 285
CIPHERHEALTH INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 286
KYRUUS, INC.: COMPANY OVERVIEW
TABLE 287
KYRUUS, INC.: SOLUTIONS OFFERED
TABLE 288
KYRUUS, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 289
KYRUUS, INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 290
RELATIENT: COMPANY OVERVIEW
TABLE 291
RELATIENT: SOLUTIONS OFFERED
TABLE 292
RELATIENT: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 293
ALIDA: COMPANY OVERVIEW
TABLE 294
ALIDA: SOLUTIONS OFFERED
TABLE 295
TWILIO INC.: COMPANY OVERVIEW
TABLE 296
TWILIO INC.: SOLUTIONS OFFERED
TABLE 297
TWILIO INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 298
TWILIO INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 299
AVAAMO: COMPANY OVERVIEW
TABLE 300
AVAAMO: SOLUTIONS OFFERED
TABLE 301
AVAAMO: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 302
CERTIFY HEALTH: COMPANY OVERVIEW
TABLE 303
CERTIFY HEALTH: SOLUTIONS OFFERED
TABLE 304
CERTIFY HEALTH: OTHER DEVELOPMENTS, JANUARY 2023–JULY 2026
TABLE 305
LUMA HEALTH INC.: COMPANY OVERVIEW
TABLE 306
LUMA HEALTH INC.: SOLUTIONS OFFERED
TABLE 307
LUMA HEALTH INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 308
LUMA HEALTH INC.: DEALS, JANUARY 2023–JULY 2026
TABLE 309
SOLUTIONREACH: COMPANY OVERVIEW
TABLE 310
SOLUTIONREACH: SOLUTIONS OFFERED
TABLE 311
SOLUTIONREACH: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 312
SALESFORCE, INC.: COMPANY OVERVIEW
TABLE 313
SALESFORCE, INC.: SOLUTIONS OFFERED
TABLE 314
SALESFORCE, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2023–JULY 2026
TABLE 315
VITAL: COMPANY OVERVIEW
TABLE 316
NEXHEALTH: COMPANY OVERVIEW
TABLE 317
COLLECTLY, INC.: COMPANY OVERVIEW
TABLE 318
BUSINESS INTEGRITY SERVICES: COMPANY OVERVIEW
TABLE 319
BAMBOO HEALTH: COMPANY OVERVIEW
TABLE 320
FACTOR ANALYSIS
TABLE 321
RISK ASSESSMENT: PATIENT EXPERIENCE TECHNOLOGY MARKET
FIGURE 1
PATIENT EXPERIENCE TECHNOLOGY MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 3
GLOBAL PATIENT EXPERIENCE TECHNOLOGY MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2023–2026
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF PATIENT EXPERIENCE TECHNOLOGY MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PATIENT EXPERIENCE TECHNOLOGY MARKET DURING FORECAST PERIOD
FIGURE 8
INCREASING ADOPTION OF DIGITAL HEALTH SOLUTIONS TO ENHANCE PATIENT ENGAGEMENT
FIGURE 9
SOFTWARE/PLATFORMS IN NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
FIGURE 10
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11
PATIENT EXPERIENCE TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12
PATIENT EXPERIENCE TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 13
PATIENT EXPERIENCE TECHNOLOGY MARKET: VALUE CHAIN ANALYSIS
FIGURE 14
PATIENT EXPERIENCE TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS
FIGURE 15
AVERAGE SELLING PRICE TREND OF PATIENT EXPERIENCE TECHNOLOGY, BY REGION, 2022–2025 (USD)
FIGURE 16
PATIENT EXPERIENCE TECHNOLOGY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 17
RECENT FUNDING ACTIVITY IN PATIENT EXPERIENCE TECHNOLOGY MARKET
FIGURE 18
GLOBAL PATENT PUBLICATION TRENDS IN PATIENT EXPERIENCE TECHNOLOGY, 2015–2026
FIGURE 19
JURISDICTION ANALYSIS OF PATIENT EXPERIENCE TECHNOLOGY PATENTS, JANUARY 2015–SEPTEMBER 2026
FIGURE 20
PATIENT EXPERIENCE TECHNOLOGY MARKET: PATENT ANALYSIS, JANUARY 2015–SEPTEMBER 2026
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 22
KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 23
NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT
FIGURE 24
ASIA PACIFIC: PATIENT EXPERIENCE TECHNOLOGY MARKET SNAPSHOT
FIGURE 25
PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION)
FIGURE 26
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET, 2025
FIGURE 27
EV/EBITDA OF KEY VENDORS
FIGURE 28
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 29
PATIENT EXPERIENCE TECHNOLOGY MARKET: BRAND/SOFTWARE COMPARISON
FIGURE 30
PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31
PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY FOOTPRINT
FIGURE 32
PATIENT EXPERIENCE TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33
NATIONAL RESEARCH CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 34
PHREESIA: COMPANY SNAPSHOT (2025)
FIGURE 35
NICE: COMPANY SNAPSHOT (2025)
FIGURE 36
IQVIA: COMPANY SNAPSHOT (2025)
FIGURE 37
TWILIO INC.: COMPANY SNAPSHOT (2025)
FIGURE 38
SALESFORCE, INC.: COMPANY SNAPSHOT (2025)
FIGURE 39
RESEARCH DESIGN
FIGURE 40
PRIMARY SOURCES
FIGURE 41
INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 42
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 43
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 44
SUPPLY-SIDE MARKET ESTIMATION
FIGURE 45
PATIENT EXPERIENCE TECHNOLOGY MARKET: REVENUE ESTIMATION APPROACH
FIGURE 46
BOTTOM-UP APPROACH
FIGURE 47
CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
FIGURE 48
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 49
TOP-DOWN APPROACH
FIGURE 50
DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in Patient Experience Technology Market